Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

NOVELION THERAPEUTICS INC. (NVLNF)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12Dec-31-11
   10-K10-K10-K10-K10-K10-K10-K10-K
Net income  -108.3-126.7-52.9-23.0-4.0-25.845.7-30.4
Depreciation and amortization   [+]26.827.12.40.60.91.01.31.4
Asset impairment charges  2.118.8   0.2  
Stock-based compensation  3.14.50.82.31.50.65.83.0
Deferred taxes  0.90.1-0.20.0-0.20.71.83.7
Change in working capital   [+]-7.5-11.013.63.40.4-1.62.25.9
Other operating activities  27.632.21.9-2.61.9-0.9-98.3-0.1
Cash from operations  -55.5-54.9-34.4-19.40.5-25.8-41.6-16.6
   
Capital expenditures   [+]-0.4-0.8-0.20.00.0-0.2-0.9-3.3
Other cash from investing    25.3 36.643.2136.232.6
Cash from investing  -0.4-0.825.30.036.743.0136.129.3
   
Cash dividends paid    -15.0  -200.0  
Issuance of common stock, net  0.40.121.55.50.5-5.87.3-16.7
Option exercises   0.5 5.5    
Financing costs  -3.0       
Other cash from financing  44.10.5-30.05.5    
Cash from financing  47.40.1-23.55.50.5-205.87.3-16.7
   
Free cash flow  -55.9-55.7-34.5-19.40.4-26.0-42.5-19.9
        Per share (diluted)  ($2.97)($2.99)($3.06)($1.86)$0.04($0.51)($0.85)($0.40)
   
Cash paid for interest  8.26.50.0     
Cash paid for income taxes  0.01.7      

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy